All of the included studies were observational cohort studies. Each study included pregnant women with either gestational diabetes or pregestational diabetes who were on insulin glargine and a control ...

NEW YORK (Reuters Health) - The use of insulin glargine, a man-made type of insulin, for diabetes during pregnancy does not increase the risk of complications for the developing baby, findings from a ...

Metformin is safe to use during pregnancy to manage diabetes, with no long-term adverse effects on the children born and their mothers for at least 11 years after childbirth, according to research ...

First and only commercially available AID technology for pregnancy use in the U.S. Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today ...

Pregnant women with type 1 diabetes face high rates of adverse outcomes linked to hyperglycemia. Narrow glycemic targets during pregnancy create added difficulty for patients and care teams. Previous ...

Prepregnancy insulin resistance was associated with impaired fertility and increased pregnancy complications such as preeclampsia for women with polycystic ovary syndrome (PCOS), according to recent ...

Spending more time in glucose range could help reduce adverse pregnancy outcomes, but available closed-loop insulin delivery systems are not customized to pregnancy-specific needs. In a randomized ...

To the Editor: In their article on the results of the Automated Insulin Delivery among Pregnant Women with Type 1 Diabetes (AiDAPT) trial, Lee et al. (Oct. 26 issue) 1 describe the use of hybrid ...

Please provide your email address to receive an email when new articles are posted on . Automated insulin delivery systems may improve time in range during pregnancy. Providers should individualize ...